Protalix BioTherapeutics
PLX
PLX
33 hedge funds and large institutions have $7.58M invested in Protalix BioTherapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 14 closing their positions.
Holders
33
Holders Change
-5
Holders Change %
-13.16%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
12
Reduced
5
Closed
14
Calls
$2.86M
Puts
$2.53M
Net Calls
+$332K
Net Calls Change
+$481K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$3.56M |
2 |
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
|
$467K |
3 |
![]()
3
Group One Trading
Chicago,
Illinois
|
$342K |
4 |
4
Walleye Trading
New York
|
$258K |
5 |
5
BlackRock
New York
|
$234K |